Next Article in Journal
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1
Next Article in Special Issue
Integrated Approaches for the Delivery of Maternal and Child Health Services with Childhood Immunization Programs in Low- and Middle-Income Countries: Systematic Review Update 2011–2020
Previous Article in Journal
Scientific and Regulatory Lessons Learnt on Building a Chemistry, Manufacturing, and Controls (CMC) Package for COVID-19 Variant Vaccine Updates in the EU—A Regulator’s Perspective
Previous Article in Special Issue
Spectrum and Incidence of Adverse Reactions Post Immunization in the Taiwanese Population (2014–2019): An Analysis Using the National Vaccine Injury Compensation Program
 
 
Article

Article Versions Notes

Vaccines 2024, 12(11), 1235; https://doi.org/10.3390/vaccines12111235
Action Date Notes Link
article xml file uploaded 30 October 2024 04:46 CET Original file -
article xml uploaded. 30 October 2024 04:46 CET Update https://www.mdpi.com/2076-393X/12/11/1235/xml
article pdf uploaded. 30 October 2024 04:46 CET Version of Record https://www.mdpi.com/2076-393X/12/11/1235/pdf
article html file updated 30 October 2024 04:49 CET Original file https://www.mdpi.com/2076-393X/12/11/1235/html
Back to TopTop